Finançament
Investigador/a: Assunta Cirella
4 finançaments 1.047.728,00 €
2021
-
Desarrolo preclínico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 STING
126.500,00 €
-
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
459.800,00 €
-
INTERLEUKIN-8 AND NEUTROPHIL EXTRACELLULAR TRAPS AS ACTIONABLE TARGET AND BIOMARKERS FOR CANCER IMMUNOTHERAPY
213.555,00 €
2018
-
H2020-ITN Tumor Treg Targeting
247.873,00 €